Sutro Biopharma, Inc. (STRO)
37.60
+0.28
(+0.75%)
USD |
NASDAQ |
May 06, 16:00
37.60
0.00 (0.00%)
After-Hours: 20:00
Sutro Biopharma Profit Margin (Quarterly) : -401.5% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AbbVie, Inc. | 4.67% |
| ACADIA Pharmaceuticals, Inc. | 96.33% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
| Savara, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | 13.77% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -70.54% |
| Return on Invested Capital | -110.4% |
| Gross Profit Margin (Quarterly) | 86.06% |
| Operating Margin (Quarterly) | -289.0% |
| Return on Net Operating Assets | -516.2% |